Department of Anaesthesiology, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Email:
Department of Anaesthesiology, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Cardiovasc J Afr. 2021;32(6):308-313. doi: 10.5830/CVJA-2020-063. Epub 2021 Feb 3.
Cardiac surgery with cardiopulmonary bypass (CPB) is known to contribute towards the incidence of acute kidney injury (AKI) and peri-operative morbidity and mortality. There are several patient, anaesthetic and surgical factors that contribute to its occurrence. It is imperative to know the profile of a patient who is likely to develop this complication to mitigate for modifiable risks. This study aimed at describing a profile of AKI in an adult patient (over the age of 18 years) following cardiac surgery on CPB. Factors associated with the development of cardiac surgery-associated acute kidney injury (CSA-AKI) are described, as well as the relationship between CSA-AKI and in-hospital mortality.
This was a contextual, descriptive and retrospective single-centre study with data of 476 adult patients admitted post cardiac surgery between January 2016 and December 2017. Data were collected from Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in South Africa. All adult patients who presented for elective cardiac surgery (coronary artery bypass graft), valvular, aortic and other cardiac surgery on CPB were included. Peri-operative factors such as patient demographics, baseline renal function, co-morbid factors, length of CPB and aortic cross-clamp time, degree of hypothermia, use of assist devices, and post-operative serum creatinine (SCr) levels were collected. Incomplete essential peri-operative data and data for patients who presented on renal replacement therapy (RRT) already were excluded. AKI was defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria.
One hundred and thirty-five (28%) patients developed CSA-AKI and 20, 5 and 3% were in KDIGO 1, 2 and 3, respectively. Older age ( = 0.024), female gender ( = 0.015), higher serum creatinine level ( = 0.025), and lower estimated glomerular filtration rate (eGFR) ( = 0.025) were associated with the development of CSA-AKI, while a history of hypertension was predictive. Forty-six of the 476 patients died. Mortality rates were significantly higher in those with AKI compared to those without [28 (21%) vs 18 (5%), respectively ( = 0.001)]. The incidence was significantly worse in those with severe kidney injury, as evidenced by mortality rates of 44 versus 5% between KDIGO 3 and KDIGO 1 ( < 0.001). Pre-operative eGFR and CSA-AKI requiring RRT were significantly associated with mortality, while pre-operative eGFR was an independent predictor of mortality (hazard ratio 0.99, 95% confidence interval: 0.97-0.99, = 0.019).
A history of hypertension was predictive of the development of CSA-AKI, and pre-operative eGFR was an independent predictor of mortality in this cohort. Both factors are modifiable.
体外循环心脏手术(CPB)已知会导致急性肾损伤(AKI)和围手术期发病率和死亡率。有几个患者、麻醉和手术因素会导致其发生。了解可能发生这种并发症的患者的特征对于减轻可改变的风险至关重要。本研究旨在描述 CPB 后成年患者(18 岁以上)心脏手术后 AKI 的特征。描述与心脏手术相关的急性肾损伤(CSA-AKI)发展相关的因素,以及 CSA-AKI 与院内死亡率之间的关系。
这是一项具有上下文、描述性和回顾性的单中心研究,纳入了 2016 年 1 月至 2017 年 12 月间在南非夏洛特·马克斯凯泽约翰内斯堡学术医院(CMJAH)接受 CPB 心脏手术后的 476 名成年患者的数据。纳入了所有接受择期心脏手术(冠状动脉旁路移植术)、瓣膜、主动脉和其他 CPB 心脏手术的成年患者。收集了围手术期因素,如患者人口统计学、基线肾功能、合并症、CPB 和主动脉阻断时间、低温程度、辅助设备使用以及术后血清肌酐(SCr)水平。排除了围手术期数据不完整和已经开始肾脏替代治疗(RRT)的患者的数据。AKI 按肾脏疾病改善全球结局(KDIGO)标准定义。
135 名(28%)患者发生 CSA-AKI,分别有 20%、5%和 3%的患者为 KDIGO 1、2 和 3 期。年龄较大(=0.024)、女性(=0.015)、血清肌酐水平较高(=0.025)和估算肾小球滤过率(eGFR)较低(=0.025)与 CSA-AKI 的发生相关,而高血压史具有预测性。476 名患者中有 46 名死亡。与无 AKI 相比,AKI 患者的死亡率显著更高[分别为 28%(21%)和 18%(5%),=0.001]。严重肾脏损伤患者的发生率明显更差,证据是 KDIGO 3 期和 KDIGO 1 期之间的死亡率分别为 44%和 5%(<0.001)。术前 eGFR 和需要 RRT 的 CSA-AKI 与死亡率显著相关,而术前 eGFR 是死亡率的独立预测因素(危险比 0.99,95%置信区间:0.97-0.99,=0.019)。
高血压史可预测 CSA-AKI 的发生,而术前 eGFR 是该队列中死亡率的独立预测因素。这两个因素都是可以改变的。